a month ago
CAPR
AnalystsBoobalan PachaiyappanBoobalan Pachaiyappan's Stock Forecasts
AnalystsBoobalan Pachaiyappan
Sectors:
Industries:
Analyst Ranking
Top 10%
#476 out of 5147 analysts
Average Return
+59.39%
Win Rate
65%17 out of 26
Risk vs Reward
Poor
Good
Boobalan Pachaiyappan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | +363.03% | $5.87 | $27.18 | 2025-11-11 - 2025-12-11 | Strong Buy |
Capricor Therapeutics IncCAPR | +268.04% | $7.39 | $27.18 | 2025-07-13 - 2025-12-11 | Strong Buy |
Cervomed IncCRVO | +247.03% | $2.36 | $8.19 | 2025-03-10 - 2025-12-11 | Strong Buy |
Gain Therapeutics IncGANX | +165.16% | $1.55 | $4.11 | 2025-08-12 - 2025-12-11 | Strong Buy |
Gain Therapeutics IncGANX | +158.49% | $1.59 | $4.11 | 2024-12-23 - 2025-12-11 | Strong Buy |
Boobalan Pachaiyappan Analyst Color
Get additional color on Boobalan Pachaiyappan's coverage of popular stocks
9 months ago
CRVO
9 months ago
CRVO
Boobalan Pachaiyappan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ovid Therapeutics IncOVID | 1 | Strong Buy | $3.00 | +81.82% | Initiates Coverage On | 2 days ago |
Cingulate IncCING | 4 | Strong Buy | $16.00 | +282.78% | Maintains | 24 days ago |
Polypid LtdPYPD | 3 | Strong Buy | $9.00 | +126.13% | Maintains | a month ago |
Capricor Therapeutics IncCAPR | 3 | Strong Buy | $13.00 | -52.17% | Maintains | a month ago |
Avidity Biosciences IncRNA | 1 | Strong Buy | $62.00 | -13.41% | Initiates Coverage On | 3 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 2 | Strong Buy | $3.00 | +341.83% | Reiterates | 4 months ago |
Longeveron IncLGVN | 2 | Strong Buy | $3.00 | +378.47% | Maintains | 4 months ago |
Gain Therapeutics IncGANX | 3 | Strong Buy | $6.00 | +45.99% | Maintains | 4 months ago |
Cervomed IncCRVO | 4 | Strong Buy | $16.00 | +95.36% | Reiterates | 4 months ago |
Verona Pharma PLCVRNA | 2 | Strong Buy | $116.00 | +8.50% | Reiterates | 6 months ago |
Entrada Therapeutics IncTRDA | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.